494 related articles for article (PubMed ID: 11716072)
21. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
Abe T; Mori T; Kohno K; Seiki M; Hayakawa T; Welgus HG; Hori S; Kuwano M
Clin Exp Metastasis; 1994 Jul; 12(4):296-304. PubMed ID: 8039304
[TBL] [Abstract][Full Text] [Related]
22. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR
Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
[TBL] [Abstract][Full Text] [Related]
23. Cell-extracellular matrix interaction in glioma invasion.
Goldbrunner RH; Bernstein JJ; Tonn JC
Acta Neurochir (Wien); 1999; 141(3):295-305; discussion 304-5. PubMed ID: 10214487
[TBL] [Abstract][Full Text] [Related]
24. [Inhibition of cellular adhesion and invasion in gliomas].
Sasaki H; Yoshida K
Nihon Rinsho; 2005 Sep; 63 Suppl 9():68-73. PubMed ID: 16201502
[No Abstract] [Full Text] [Related]
25. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
26. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.
Uchima Y; Sawada T; Nishihara T; Maeda K; Ohira M; Hirakawa K
Pancreas; 2004 Aug; 29(2):123-31. PubMed ID: 15257104
[TBL] [Abstract][Full Text] [Related]
27. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.
Uhm JH; Dooley NP; Villemure JG; Yong VW
Clin Exp Metastasis; 1996 Oct; 14(5):421-33. PubMed ID: 8871536
[TBL] [Abstract][Full Text] [Related]
28. Suppression of invasion in human U87 glioma cells by adenovirus-mediated co-transfer of TIMP-2 and PTEN gene.
Lu W; Zhou X; Hong B; Liu J; Yue Z
Cancer Lett; 2004 Oct; 214(2):205-13. PubMed ID: 15363547
[TBL] [Abstract][Full Text] [Related]
29. Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells.
Nuttall RK; Pennington CJ; Taplin J; Wheal A; Yong VW; Forsyth PA; Edwards DR
Mol Cancer Res; 2003 Mar; 1(5):333-45. PubMed ID: 12651907
[TBL] [Abstract][Full Text] [Related]
30. The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase.
Zhang J; Sarkar S; Yong VW
Carcinogenesis; 2005 Dec; 26(12):2069-77. PubMed ID: 16033774
[TBL] [Abstract][Full Text] [Related]
31. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
[TBL] [Abstract][Full Text] [Related]
32. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.
Kubiatowski T; Jang T; Lachyankar MB; Salmonsen R; Nabi RR; Quesenberry PJ; Litofsky NS; Ross AH; Recht LD
J Neurosurg; 2001 Sep; 95(3):480-8. PubMed ID: 11565871
[TBL] [Abstract][Full Text] [Related]
33. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity.
Morini M; Mottolese M; Ferrari N; Ghiorzo F; Buglioni S; Mortarini R; Noonan DM; Natali PG; Albini A
Int J Cancer; 2000 Aug; 87(3):336-42. PubMed ID: 10897037
[TBL] [Abstract][Full Text] [Related]
34. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.
Emenaker NJ; Basson MD
J Surg Res; 1998 Apr; 76(1):41-6. PubMed ID: 9695737
[TBL] [Abstract][Full Text] [Related]
35. Membrane type-matrix metalloproteinase and tumor invasion.
Seiki M
Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():23-32. PubMed ID: 8814990
[No Abstract] [Full Text] [Related]
36. Complex roles of matrix metalloproteinases in tumor progression.
Powell WC; Matrisian LM
Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():1-21. PubMed ID: 8814982
[No Abstract] [Full Text] [Related]
37. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis.
Duffy MJ; Maguire TM; Hill A; McDermott E; O'Higgins N
Breast Cancer Res; 2000; 2(4):252-7. PubMed ID: 11250717
[TBL] [Abstract][Full Text] [Related]
38. Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas.
Van Meter TE; Broaddus WC; Rooprai HK; Pilkington GJ; Fillmore HL
Neuro Oncol; 2004 Jul; 6(3):188-99. PubMed ID: 15279711
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases and their biological function in human gliomas.
Chintala SK; Tonn JC; Rao JS
Int J Dev Neurosci; 1999; 17(5-6):495-502. PubMed ID: 10571411
[TBL] [Abstract][Full Text] [Related]
40. Novel anti IGFBP2 single chain variable fragment inhibits glioma cell migration and invasion.
Patil SS; Railkar R; Swain M; Atreya HS; Dighe RR; Kondaiah P
J Neurooncol; 2015 Jun; 123(2):225-35. PubMed ID: 25944386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
